Post from another board:
By: sixersadvantcom
11 Aug 2009, 08:55 PM EDT
Rating: Rate this post: Msg. 266 of 267
Jump to msg. #
Second Quarter Results.
1.Gross Margin 56.6%, Great.
2.Operating Expenses Down 31%, Great.
3.Revenue $3.47 million, Room for improvement but the increase of backlog to $4.3 million is the spoonful of sugar which helps the medicine go down.
4.Positive EBITDA good but looking for positive earnings.
5.Overall very good especially considering the economic climate.
bob
Send stock manipulators to: enforcement@sec.gov-and to jail.